Insulinotropic and gastrin-releasing action of gastrin-releasing peptide (GRP)

George H. Greeley, James C. Thompson

Research output: Contribution to journalArticlepeer-review

63 Scopus citations


The effect of intravenous administration of gastrin-releasing peptide (GRP) on serum gastrin and insulin levels was studied in ad libitum fed and 24-h fasted rats. Administration of GRP (55 μg/kg body weight) caused a significant (P < 0.05) elevation in serum gastrin levels at 10, 30, 60, and 120 min in the rats fed ad libitum, whereas in the fasted rats, gastrin levels rose significantly only at 10 min. GRP did not cause insulin release in fasted rats, but in the fed rats, it led to a significant elevation in serum insulin levels at 10 and 30 min, in comparison to controls. GRP appears to have an insulinotropic action in addition to a gastrin-releasing effect.

Original languageEnglish (US)
Pages (from-to)97-103
Number of pages7
JournalRegulatory Peptides
Issue number2
StatePublished - Mar 1984
Externally publishedYes


  • GRP
  • fasted rats
  • fed rats
  • gastrin
  • insulin

ASJC Scopus subject areas

  • Physiology
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Cellular and Molecular Neuroscience


Dive into the research topics of 'Insulinotropic and gastrin-releasing action of gastrin-releasing peptide (GRP)'. Together they form a unique fingerprint.

Cite this